Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,058.54 +974.33 (+1.45%) CMC Crypto 200
1,374.09 +43.48 (+3.27%)
Zevra Therapeutics, Inc. (ZVRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.23 |
| Open | 6.31 |
| Bid | 6.21 x 300 |
| Ask | 6.27 x 200 |
| Day's range | 6.10 - 6.42 |
| 52-week range | 3.89 - 7.28 |
| Volume | |
| Avg. volume | 302,729 |
| Market cap | 260.329M |
| Beta (5Y monthly) | 1.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.32 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.00 |
Simply Wall St.Zevra Therapeutics Insider Confidence Rewarded, Stock Hits US$235m Market Cap
Last week, Zevra Therapeutics, Inc. ( NASDAQ:ZVRA ) insiders, who had purchased shares in the previous 12 months were...
ZacksZevra (ZVRA) Rises on Update on Niemann-Pick Disease Type C Drug
The FDA will meet with its Genetic Metabolic Diseases Advisory Committee to review Zevra's (ZVRA) new drug application for pipeline candidate arimoclomol. Shares of Zevra gains on the news.
ZacksZevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?
Zevra Therapeutics (ZVRA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2024 Yahoo. All rights reserved.